Comment · Tue, January 28, 2014 · Ceretropic
Expanding hippocompal volume with NSI-189 and Tianeptine.
Original post in this thread
Psychoactivekittykat · 15 points
Tianeptine reduces stress-induced reductions in hippocampal volume. NSI-189 IIRC continuously expands hippocompal volume. IIRC increased, continuous expansion of the hippocampal volume can lead to drastic improvements in cognitive performance, working memory, depth perception, and motor-skill function.
NSI's expanding properties, and tianpetines reduction reducing properties, when combined, could they lead to even more hippocampal volume expansion? Leading to more profound effects?
* http://en.wikipedia.org/wiki/NSI-189
* http://investor.neuralstem.com/phoenix.zhtml?c=203908&p=irol-newsArticle&ID=1708123&highlight=
* http://clinicaltrials.gov/ct2/show/NCT01310881?term=neuralstem&rank=1
* http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902200/
What they were answering
LordDaedalus · 1 points
Ah, and you've double checked the patent? I was actually looking at that patent earlier today which lead me to looking through threads on NSI-189. How do you know it would have the same binding profiles? I'm very curious.
u/MisterYouAreSoDumb · Ceretropic
Yes, we've checked.
The modification to the molecule that we have done does not affect the binding of the key functional groups. In fact, it may even lead to increased lipid solubility, which could mean lower doses or longer durations.